as per atttachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharma East India Hospitals reported strong full-year FY25 results with total revenue rising to ₹30.19 crore, up about 27% from ₹23.83 crore in FY24. Profit after tax jumped to ₹1.24 crore from ₹66.30 lakh, nearly doubling year-on-year, while EPS improved to ₹3.79 from ₹2.02. For Q4 alone, revenue dipped to ₹6.22 crore from ₹7.11 crore a year earlier, but the company remained profitable. Operating cash flow turned strongly positive at ₹6.69 crore versus a negative ₹1.13 crore last year, and short-term borrowings fell sharply from ₹3.87 crore to ₹1.09 crore. Statutory auditors Gopal Sharma & Co issued an unmodified (clean) opinion on the results.
The sharp rise in full-year profits, cleaner balance sheet with reduced debt, and swing to positive operating cash flow are positive signals for shareholders. However, the Q4 revenue decline and small absolute profit base mean the stock may see limited excitement despite the strong annual numbers.